Therapeutic potential of natural compounds that regulate the activity of protein kinase C

被引:46
作者
Carter, CA
Kane, CJM
机构
[1] WinSwift Sci, Nat Therapeut Biol Div, Little Rock, AR 72223 USA
[2] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA
关键词
antioxidants; retinoids; vitamin E; vitamin C; ethanol; cancer; diabetes; fetal alcohol syndrome;
D O I
10.2174/0929867043364090
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinase C (PKC) is a family of serine/threonine kinases that regulates a variety of cell functions including proliferation, gene expression, cell cycle, differentiation, cytoskeletal organization, cell migration, and apoptosis. The PKC signal transduction cascade coordinates complex physiological events including normal tissue function and repair. Disruption of the Cellular environment through genetic mutation, disease, injury, or exposure to pro-oxidants, alcohol. or other insults can induce pathological PKC activation. Aberrant PKC activation can lead to diseases of cellular dysregulation such as cancer and diabetes. Can aberrant activation of PKC be reversed? Even 25 years after the identification of PKC, therapeutic regulation of PKC activity remains an emerging field. Because the function of each isoform remains to be elucidated, isoform specific control of gene expression is a current challenge. Natural compounds are important regulators of PKC activity, with both preventive and therapeutic efficacy. Antioxidants including vitamin A (retinoids), vitamin C (ascorbic acid) and vitamin E (tocopherols) show promise for reversal of PKC activation. beta-carotcne and retinoids function as anticarcinogenic agents and antagonize the biological effects of pro-oxidants on PKC. Vitamin E reverses the deleterious effects of hyperglycemia and diabetes by down-regulating PKC activity. Antioxidants in red wine provide cardioprotective effects. However, alcohol consumption also induces oxidative stress and disrupts PKC and retinoid function in the fetus and the adult. This review examines modulation of PKC activity by natural compounds and pharmacologic analogues which can be used effectively to prevent or treat common diseases associated with aberrant activation of PKC.
引用
收藏
页码:2883 / 2902
页数:20
相关论文
共 322 条
[81]  
END DW, 1987, RES COMMUN CHEM PATH, V56, P75
[82]  
Engers R, 2000, BRIT J CANCER, V82, P1063
[83]   Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states [J].
Farese, RV .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (01) :E1-E11
[84]   PROTEIN-KINASE C INHIBITION BY PLANT FLAVONOIDS - KINETIC MECHANISMS AND STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
FERRIOLA, PC ;
CODY, V ;
MIDDLETON, E .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (10) :1617-1624
[85]   CELLULAR, IMMUNOLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF TOPICAL RETINOIC ACID-TREATED HUMAN SKIN [J].
FISHER, GJ ;
ESMANN, J ;
GRIFFITHS, CEM ;
TALWAR, HS ;
DUELL, EA ;
HAMMERBERG, C ;
ELDER, JT ;
KARABIN, GD ;
NICKOLOFF, BJ ;
COOPER, KD ;
VOORHEES, JJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (05) :699-707
[86]   Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl beta-glucuronide [J].
Formelli, F ;
Barua, AB ;
Olson, JA .
FASEB JOURNAL, 1996, 10 (09) :1014-1024
[87]   Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: Possible role in AP-1-mediated proliferation of ER-negative endometrial cancer [J].
Fournier, DB ;
Chisamore, M ;
Lurain, JR ;
Rademaker, AW ;
Jordan, VC ;
Tonetti, DA .
GYNECOLOGIC ONCOLOGY, 2001, 81 (03) :366-372
[88]   Potential new medical therapies for diabetic retinopathy: Protein kinase C inhibitors [J].
Frank, RN .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (05) :693-698
[89]   INHIBITION OF OXIDATION OF HUMAN LOW-DENSITY-LIPOPROTEIN BY PHENOLIC SUBSTANCES IN RED WINE [J].
FRANKEL, EN ;
KANNER, J ;
GERMAN, JB ;
PARKS, E ;
KINSELLA, JE .
LANCET, 1993, 341 (8843) :454-457
[90]  
Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792